Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium

Regenerative Medicine

Volumn 1, Issue 2, 2006, Pages 235-253

  Spillmann, Frank ^a,b   Graiani, Gallia ^a,c   van Linthout, Sophie ^a,b   Meloni, Marco ^a,d   Campesi, Ilaria ^a,b   Lagrasta, Costanza ^c   Westermann, Dirk ^b   Tschöpe, Carsten ^b   Quaini, Federico ^c   Emanueli, Costanza ^a,d   Madeddu, Paolo ^a,d,e  

^a NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e IRCCS MULTIMEDICA   (Italy)

Author keywords

Cardiac progenitor cells; Endothelial progenitor cells; Myocardial infarction; Therapeutic angiogenesis; Tissue kallikrein

Indexed keywords

TISSUE KALLIKREIN;

ANIMAL; ARTICLE; CELL SURVIVAL; CORONARY BLOOD VESSEL; CYTOLOGY; DIASTOLE; EVALUATION; GENE THERAPY; GENE TRANSFER; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; METABOLISM; MORTALITY; MOUSE; MOUSE STRAIN; PHYSIOLOGY; STEM CELL; SYSTOLE; TRANSGENIC MOUSE;

ANIMALS; CELL SURVIVAL; CORONARY VESSELS; DIASTOLE; GENE THERAPY; GENE TRANSFER TECHNIQUES; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; STEM CELLS; SYSTOLE; TISSUE KALLIKREINS; VENTRICULAR REMODELING;

EID: 33947617586     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/17460751.1.2.235     Document Type: Article

References (36)

1. Losordo DW, Vale PR, Symes JF et al.: Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800-2804 (1998).
2. Rosengart TK, Lee LY, Patel SR et al.: Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100, 468-474 (1999).
3. Grines CL, Watkins MW, Helmer G et al.: Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105, 1291-1297 (2002).
4. Menasche P: Cell transplantation in myocardium. Ann. Thorac. Surg. 75(suppl. 6), S20-S28 (2003).
5. Strauer BE, Brehm M, Zeus T et al.: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913-1918 (2002).
6. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP: Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361, 47-49 (2003).
7. Assmus B, Schachinger V, Teupe C et al.: Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106, 3009-3017 (2002).
8. Kawamoto A, Tkebuchava T, Yamaguchi J et al.: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107, 461-468 (2003).
9. Laflamme MA, Murry CE: Regenerating the heart. Nat. Biotechnol. 23, 845-856 (2005).
10. Emanueli C, Madeddu P: Targeting kinin receptors for the treatment of tissue ischaemia. Trends Pharmacol. Sci. 22, 478-484 (2001).
11. Tschope C, Heringer-Walther S, Koch M et al.: Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction. J. Hypertens. 18, 223-228 (2000).
12. Tschope C, Heringer-Walther S, Koch M et al.: Upregulation of bradykinin B1-receptor expression after myocardial infarction. Br. J. Pharmacol. 129, 1537-1538 (2000).
13. Emanueli C, Minasi A, Zacheo A et al.: Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation 103, 125-132 (2001).
14. Emanueli C, Salis MB, Stacca T et al.: Targeting kinin B(1) receptor for therapeutic neovascularization. Circulation 105, 360-366 (2002).
15. Emanueli C, Graiani G, Salis MB, Gadau S, Desortes E, Madeddu P: Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in Type 1 diabetic mice. Diabetes 53, 1096-1103 (2004).
16. Emanueli C, Salis MB, Van Linthout S et al.: Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer. Circulation 110, 1638-1644 (2004).
17. Yin H, Chao L, Chao J: Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J. Biol. Chem. 280(9), 8022-8030 (2005).
18. Emanueli C, Zacheo A, Minasi A et al.: Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle. Arterioscler. Thromb. Vasc. Biol. 20, 2379-2385 (2000).
19. Graiani G, Lagrasta C, Migliaccio E et al.: Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension 46, 433-440 (2005).
20. Asahara T, Takahashi T, Masuda H et al.: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18, 3964-3972 (1999).
21. Asahara T, Murohara T, Sullivan A et al.: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967 (1997).
22. Yaoita H, Ogawa K, Maehara K, Maruyama Y: Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97, 276-281 (1998).
23. Asahara T, Masuda H, Takahashi T et al.: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85, 221-228 (1999).
24. Beltrami AP, Barlucchi L, Torella D et al.: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776 (2003).
25. Cheng W, Kajstura J, Nitahara JA et al.: Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp. Cell Res. 226, 316-327 (1996).
26. Liu Y, Rabinovitch A, Suarez-Pinzon W et al.: Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic β-cells from apoptosis. Hum. Gene Ther. 7, 1719-1726 (1996).
27. Condorelli G, Morisco C, Stassi G et al.: Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99, 3071-3078 (1999).
28. Dimmeler S, Haendeler J, Nehls M, Zeiher AM: Suppression of apoptosis by nitric oxide via inhibition of interleukin-1betaconverting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185, 601-607 (1997).
29. Delikouras A, Hayes M, Malde P, Lechler RI, Dorling A: Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-αmediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation 71, 599-605 (2001).
30. Harris MB, Ju H, Venema VJ et al.: Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J. Biol. Chem. 276, 16587-16591 (2001).
31. Aucher A, Heeschen C, Mildner-Rihm C et al.: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 1370-1376 (2003).
32. Schaper W, Buschmann I: Arteriogenesis, the good and bad of it. Cardiovasc. Res. 43, 835-837 (1999).
33. Oh H, Bradfute SB, Gallardo TD et al.: Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA 100, 12313-12318 (2003).
34. Martin CM, Meeson AP, Robertson SM et al.: Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 265, 262-275 (2004).
35. Cai CL, Liang X, Shi Y et al.: Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5, 877-889 (2003).
36. Kumar P, Miller AI, Polverini PJ: p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. J. Biol. Chem. 279, 43352-43360 (2004).